Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Annals of Internal Medicine|January 15, 1994
Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. A report from the Eastern Cooperative Oncology Group (ECOG)J M Rowe, N Ciobanu, J Ascensao, et al.
Bone Marrow Transplantation|May 29, 2007
Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphomaM Tomblyn, L J Burns, B Blazar, et al.
Blood|May 1, 1985
Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: analysis of prognostic factorsB Bostrom, R D Brunning, P McGlave, et al.
The American Journal of Medicine|March 1, 1983
Bone marrow transplantation for non-Hodgkin's lymphoma in children and young adults. A pilot studyM O'Leary, N K Ramsay, M E Nesbit, et al.
Transplantation|September 1, 1990
T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host diseaseA H Filipovich, D Vallera, P McGlave, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemiaP A Cassileth, D P Harrington, J D Hines, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 1997
Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSFD Weisdorf, J Miller, C Verfaillie, et al.
Transfusion|February 1, 1989
Successful allogeneic cryopreserved marrow transplantationL C Lasky, N Van Buren, D J Weisdorf, et al.
Blood|August 1, 1982
Allogeneic bone marrow transplantation in acute nonlymphocytic leukemia: a pilot studyJ H Kersey, N K Ramsay, T Kim, et al.
Blood|July 15, 1996
Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protectiveH Enright, S M Davies, T DeFor, et al.
Pageof 7